1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)" is currently closed and not accepting applications.
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) is sponsored by National Center for Advancing Translational Sciences (NCATS) / NIH. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NOT-TR-25-009: Notice of Extension for PAR-25-157 Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) Notice of Extension for PAR-25-157 Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) December 10, 2024 - Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed).
See NOFO PAR-25-157 National Center for Advancing Translational Sciences ( NCATS ) The purpose of this Notice is to inform applicants that effective immediately the National Center for Advancing Translational Sciences ( NCATS ) is extending PAR-25-157 Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) by one Council round.
The following text in bold and italics has been updated to reflect the extension: Part 1.
Overview Information Application Due Dates Review and Award Cycles New Renewal / Resubmission / Revision (as allowed) AIDS Scientific Merit Review Advisory Council Review Earliest Start Date June 19, 2025 June 19, 2025 Not Applicable October 2025 January 2026 April 2026 June 18, 2026 June 18, 2026 Not Applicable October 2026 January 2027 April 2027 Expiration Date: June 19, 2026 All other aspects of the NOFO remain the same.
Please direct all inquiries to: National Center for Advancing Translational Sciences (NCATS) Weekly TOC for this Announcement NIH... Turning Discovery Into Health ®
According to the current listing, eligibility includes: Eligibility is broad and includes various domestic U. S. Confirm the full requirements in the official notice before applying.
The current listing shows $275,000 over 2 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 18, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) is funded by National Center for Advancing Translational Sciences (NCATS) / NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Advance from NIH SBIR Phase I to Phase II with tips on demonstrating feasibility, building a commercialization plan, and securing $1M in funding.
Read articlePAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read article